Tislelizumab combined with anlotinib and chemotherapy (XELOX) in the treatment of advanced gastric carcinoma: Preliminary results of a single-arm, open-label phase I/IIa trial (TALENT study).

被引：0
|
作者：
Chen, Xiaofeng
Wang, Deqiang
Yuan, Yuan
Tang, Jie
Guo, Fen
Chen, Yizhang
Ding, Junli
Hong, Tingting
Lu, Binbin
Li, Wei
Wang, Rong
Tian, Yitong
Pan, Lanlan
Zhang, Jiaguang
Zhang, Xinyi
Xu, Tongpeng
Xu, Hao
Shu, Yongqian
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Peoples R China
[2] Jiangsu Univ, Affiliated Hosp, Canc Therapy Ctr, Dept Med Oncol, Zhenjiang, Jiangsu, Peoples R China
[3] Xuzhou Cent Hosp, Xuzhou, Jiangsu, Peoples R China
[4] Jiangsu Peoples Hosp, Liyang Branch, Dept Oncol, Liyang, Peoples R China
[5] Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China
[6] Nanjing Med Univ, Affiliated Hosp 1, Dept Oncol, Nanjing, Peoples R China
[7] Nanjing Med Univ, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China
[8] Jiangnan Univ, Affiliated Hosp, Wuxi, Jiangsu, Peoples R China
[9] Nanjing Med Univ, Affiliated Hosp 2, Dept Med Oncol, Nanjing, Peoples R China
[10] Soochow Univ, Affiliated Hosp 1, Dept Oncol, Suzhou, Peoples R China
[11] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
396
引用
收藏
页码：396 / 396
页数：1
相关论文
共 50 条
  • [41] Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients
    Tomita, Yoshihiko
    Tatsugami, Katsunori
    Nakaigawa, Noboru
    Osawa, Takahiro
    Oya, Mototsugu
    Kanayama, Hiroomi
    Kondoh, Chihiro Nakayama
    Sassa, Naoto
    Nishimura, Kazuo
    Nozawa, Masahiro
    Masumori, Naoya
    Miyoshi, Yasuhide
    Kuroda, Shingo
    Tanaka, Shingo
    Kimura, Akiko
    Tamada, Satoshi
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (11) : 952 - 959
  • [42] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Lin, Shi-Ming
    Lu, Sheng-Nan
    Chen, Ping-Tsung
    Jeng, Long-Bin
    Chen, Shinn-Cherng
    Hu, Chi-Tan
    Yang, Sien-Sing
    Le Berre, Marie-Aude
    Liu, Xuan
    Mitchell, David Y.
    Prins, Klaas
    Grevel, Joachim
    Pena, Carol A. E.
    Meinhardt, Gerold
    HEPATOLOGY INTERNATIONAL, 2017, 11 (02) : 199 - 208
  • [43] HATT: a phase IV, single-arm, open-label study of sorafenib in Taiwanese patients with advanced hepatocellular carcinoma
    Shi-Ming Lin
    Sheng-Nan Lu
    Ping-Tsung Chen
    Long-Bin Jeng
    Shinn-Cherng Chen
    Chi-Tan Hu
    Sien-Sing Yang
    Marie-Aude Le Berre
    Xuan Liu
    David Y. Mitchell
    Klaas Prins
    Joachim Grevel
    Carol A. E. Peña
    Gerold Meinhardt
    Hepatology International, 2017, 11 : 199 - 208
  • [44] Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: A single-arm, open-label, phase 2 trial
    Wei, Zhigong
    Zhu, Yuchun
    Cai, Lei
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Neoadjuvant tislelizumab with afatinib for locally advanced head and neck squamous cell carcinoma (neoCHANCE-1): An open-label, single-arm, phase 2 study
    Wei, Zhigong
    Chen, Huijiao
    Cai, Lei
    Chen, Fei
    Liu, Jun
    Peng, Xingchen
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] Anlotinib plus sintilimab in patients with recurrent advanced endometrial cancer: A prospective open-label, single-arm, phase II clinical trial.
    Wei, Wei
    Ban, Xiaohua
    Yang, Fan
    Huang, Yongwen
    Li, Jibin
    Qiu, Ya
    Cheng, Xiaqin
    Li, Jundong
    Zheng, Min
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [47] Perioperative adebrelimab combined with chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: A single-arm, open-label, multicenter study.
    Dai, Liang
    Wu, Yaya
    Tian, Ziqiang
    Ma, Jianqun
    Zhao, Changhong
    Zhuang, Bo
    Chen, Keneng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [48] Updated results of paclitaxel and cisplatin in combination with anlotinib as first-line treatment for patients with advanced ESCC: A multicenter, single-arm, open-label phase. clinical trial.
    Li, Ning
    Wu, Tao
    Hong, Yong-Gui
    Guo, Yanzhen
    Cheng, Yufeng
    Li, Baosheng
    Wang, Junsheng
    Luo, Suxia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 376 - 376
  • [49] Centchroman as First-line Treatment for Mastalgia: Results of an Open-label, Single-arm Trial
    Rathi, Jalaj
    Chawla, Inderjit
    Singh, Karnail
    Chawla, Arjun
    BREAST JOURNAL, 2016, 22 (04): : 407 - 412
  • [50] Surufatinib in combination with toripalimab in patients with advanced neuroendocrine carcinoma: Results from a multicenter, open-label, single-arm, phase II trial.
    Shen, Lin
    Yu, Xianjun
    Lu, Ming
    Zhang, Xing
    Cheng, Ying
    Zhang, Yanqiao
    Li, Zhiping
    Xu, Jianming
    Weng, Desheng
    Wu, Chunjiao
    Ma, Yue
    Cheng, Ke
    Wang, Wenquan
    Gao, Heli
    Li, Yi
    Zhou, Jinghong
    Shi, Haiyan
    Tan, Panfeng
    Su, Weiguo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345